AL
Altis Labs
Canada · Healthtech
AI software that uses clinical-trial imaging to measure treatment response and predict patient outcomes.
Imaging measures for drug development
Altis Labs helps biopharmaceutical companies assess whether experimental therapies are benefiting patients. Its IPRO models analyse CT scans collected during clinical trials to generate imaging-based predictions of patient outcomes.
The software turns routinely collected scans into measures for evaluating treatment response. Altis works with biopharma sponsors and clinical researchers, aiming to give trial teams earlier evidence for development and trial-design decisions.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $25M | Benchstrength — ParticipantFusion Fund — ParticipantInnovation Endeavors — ParticipantLumira Ventures — Participant |